期刊文献+

蚓激酶胶囊治疗椎基底动脉供血不足30例疗效观察 被引量:3

下载PDF
导出
摘要 目的探讨蚓激酶胶囊在椎基底动脉供血不足治疗中的临床应用。方法对60例椎基底动脉供血不足患者,随机分为两组,分别应用蚓激酶胶囊及复方丹参注射后观察治疗效果。结果蚓激酶胶囊能使纤维蛋白原下降(P<0.001),血粘度下降(P<0.05),表明该药能明显改善高粘状态以及脑的微循环,可以治疗椎基底动脉供血不足。结论蚓激酶胶囊对局灶性脑缺血的血管内皮细胞具有一定的保护作用,治疗椎基底动脉供血不足优于复方丹参,在椎基底动脉供血不足治疗中的应用安全有效。
作者 陈研茹
出处 《海南医学》 CAS 2009年第7期64-65,共2页 Hainan Medical Journal
  • 相关文献

参考文献4

二级参考文献16

  • 1The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med, 1995, 333: 1581-1587.
  • 2Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Stroke Study (ECASS). JAMA,1995, 274: 1017-1025.
  • 3Albers GW, Bates VE, Clark WM, et al. Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study. JAMA,2000, 283: 1145-1150.
  • 4Madhavan R, Jacobs BS, Levine SR. Stroke trials: what have we learned? Neurol Res, 2002, 24Suppll : S27-S32.
  • 5Elger B, Hornberger W, Schwarz M, et al. MRI study on delayed ancrod therapy of focal cerebral ischaemia in rats. Eur J Pharmacol,1997, 336: 7-14.
  • 6Hossmann V, Heiss WD, Bewermeyer H, et al. Controlled trial of ancrod in ischemic stroke. Arch Neurol, 1983, 40: 803-808.
  • 7Olinger CP, Brott TG, Barsan WG, et al. Use of ancrod in acute or progressing ischemic cerebral infarction. Ann Emerg Med, 1998,17 : 1208-1209.
  • 8The Ancrod Stroke Study Investigators. Ancrod for the treatment of acute ischemic brain infarction. Stroke, 1994, 25: 1755-1759.
  • 9Sherman DG, Atkinson RP, Chippendale T, et al. Intravenous ancrod for treatment of acute ischemic stroke. JAMA, 2000, 283:2395 -2403.
  • 10Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement.JAMA, 1996, 276: 637-639.

共引文献286

同被引文献32

  • 1毛蕾.蚓激酶对高黏血症患者的血液流变学影响[J].中国医药指南,2008,6(21). 被引量:10
  • 2卢长明,周传强.倍他司汀联合银杏达莫治疗52例椎基底动脉供血不足性眩晕的疗效观察[J].华西药学杂志,2010,25(6):765-766. 被引量:5
  • 3张国平,金惠铭,张明,等.蚂激酶抗凝、纤溶机制及其与组织纤溶酶原激活剂的关系.中华老年医学杂志,1998,17(6):366-369.
  • 4Schonbeck U, Gerdes N, Varo N, et al. Oxidizedlow-density lipo- protein augments and 3-hydroxy-3methylglutaryl coenzyme A re- ductase inhibitorslimitCD40 a nd C1MOL expression in hum a nvascularcells. Circulation ,2002,106 ( 13 ) :2888-2893.
  • 5Iketa U, Shimada K. Statins and monocytes. Lancet, 1999,17 (9) : 1521-1525.
  • 6Musial J, Undas A, Gajewaki P, et al. Antiginflammatory effects of simvastatin in subjects with hypercholesterolemia. Int J Cardiol, 2001,77(10) :247-253.
  • 7John S,Schneider MP, Belies C, et al. Lipidindependenteffects of statins on endothelialfunction and bioavailability of nitric oxide in- hypercholesterolemic patients. Am Heart J,2005,149 (7) :473.
  • 8Chen Z, Yang Y, Miao H, et al. Endovascular treatment for large and giant fusiform aneurysms of the vertebrobasilar arter- ies [ J ]. Clinical Imaging, 2013,37 ( 2 ) : 227 -231.
  • 9Schoen, Jessica, Boysen, Megan, Warren, Chase . Verte- brobasilar Artery Occlusion[ J ]. Western Journal of Emergency Medicine,2011,12(2) :13-16.
  • 10邵卫,黄蓓,潘宋斌.银杏达莫联合倍他司汀治疗椎—基底动脉缺血性眩晕疗效观察[J].湖北中医学院学报,2008,10(2):29-30. 被引量:3

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部